Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan 15;14(2):334-43.
doi: 10.1016/j.bmc.2005.08.017. Epub 2005 Oct 10.

Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum

Affiliations

Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum

Marc O Anderson et al. Bioorg Med Chem. .

Abstract

A parallel synthetic strategy to the 9-aminoacridine scaffold of the classical anti-malarial drug quinacrine (2) is presented. The method features a new route to 9-chloroacridines that utilizes triflates of salicylic acid derivatives, which are commercially available in a variety of substitution patterns. The route allows ready variation of the two diversity elements present in this class of molecules: the tricyclic aromatic heterocyclic core, and the disubstituted diamine sidechain. In this study, a library of 175 compounds was designed, although only 93 of the final products had purities acceptable for screening. Impurity was generally due to incomplete removal of 9-acridones (18), a degradation product of the 9-chloroacridine synthetic intermediates. The library was screened against two strains of Plasmodium falciparum, including a model of the drug-resistant parasite, and six novel compounds were found to have IC(50) values in the low nanomolar range.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of common quinoline and acridine anti-malarial compounds.
Figure 2
Figure 2
A parallel synthetic strategy to generate libraries of 9-aminoacridines.
Scheme 1
Scheme 1
Synthesis of 9-chloroacridines. Reagents and conditions: (a) MeI (1.05 eq.), Cs2CO3 (0.5 eq.) DMF (90-100% yield). (b) Tf2O (1.1 eq.), Et3N (2.0 eq.), CH2Cl2, −78 °C to rt (95-100% yield). (c) substituted anilines 6 (1.05 eq.), Pd(OAc)2 (0.05 eq.), BINAP (0.08 eq.), Cs2CO3 (1.4 eq.), toluene. (d) Ba(OH)2-8H2O (2.5 eq.), CH3OH, 80 °C overnight; (e) POCl3 (neat) 120 °C, 1h (5-50% yield).
Scheme 2
Scheme 2
Synthesis of diamines. Reagents and conditions: (a) 2-nitrobenzenesulfonyl chloride (0.1 eq.), CH2Cl2, °C to rt, overnight (70 g scale, 85% yield). (b) carboxylic anhydrides (14) (1.2 eq.), pyridine (1.1 eq.), THF (90-100% yields). (c) BH3·dimethylsulfide complex (4.0 eq.), THF, 60 °C, 30 min. (67-77% yields) (d) aldehydes 16 (1.5 eq.), sodium triacetoxyborohydride (1.5 eq.), THF, sonicated, 35 °C, 1h. (e) benzenethiol (5 eq.), Cs2CO3 (2.5 eq.), degassed CH3CN under argon.
Scheme 3
Scheme 3
Coupling of 9-chloroacridines with diamines. Reagents and conditions: (a) phenol (15 eq.), Cs2CO3 (1 eq.), 3Å molecular sieves, DMSO, 100 °C, 2 h. (b) diamines (9) (4 eq.), DMSO, 100 °C, 4h; then methyl isocyanate polystyrene resin (NovaBiochem, 8 eq.), overnight, rt.
Figure 3
Figure 3
Composition of 9-chloroacridine (7) chemset.
Figure 4
Figure 4
Composition of disubstituted diamine (9) chemset.
Figure 3
Figure 3
Relative activity of the library defined in Table 3 against P. falciparum strains 3D7 and W2 cultured in human erythrocytes (measured at fixed concentration: 30 nM). Data is represented in blue scale, as percent parasite growth relative to un-treated controls, with darker squares indicating a higher activity against the parasites. Omitted entries are due to failure during synthesis.
Figure 5
Figure 5
Structures and EC50 values of the most active compounds against P. falciparum strains 3D7 and W2 in cultured human erythrocytes, as well as for quinacrine (2) and chloroquine (3). Activity at a series of 12 concentrations was determined as percent parasite growth relative to un-treated controls, EC50 values were determined with SigmaPlot.

References

    1. Sachs J, Malaney P. Nature. 2002;415:680–5. - PubMed
    1. Kitron U, Spielman A. Rev. Infect. Dis. 1989;11:391–406. - PubMed
    1. Gilles HM. Management of Severe Malaria: A Practical Handbook. 2nd ed. World Health Organization; Geneva: 2000.
    1. Ridley RG. Nature. 2002;415:686–93. - PubMed
    1. Foley M, Tilley L. Pharmacol. Ther. 1998;79:55–87. - PubMed

LinkOut - more resources